Literature DB >> 6621685

Diacylglycerol and phorbol ester stimulate secretion without raising cytoplasmic free calcium in human platelets.

T J Rink, A Sanchez, T J Hallam.   

Abstract

An increase in cytoplasmic free calcium, [Ca2+]i, is thought to be the trigger for secretory exocytosis in many cells. In blood platelets, large rises in [Ca2+]i can cause secretion and calcium has been regarded as the final common activator not only for secretion but also for shape-change and aggregation. We have shown that while thrombin and platelet-activating factor (PAF) normally elevate [Ca2+]i, they can also stimulate shape-change and secretion even when the [Ca2+]i rise is suppressed. The present results strongly implicate diacylglycerol, produced by stimulus-dependent breakdown of phosphoinositide, in this calcium-independent activation. Exogenous diacylglycerol activates a protein kinase (C-kinase) in platelets as do PAF, thrombin and collagen. 12-O-tetradecanoyl phorbol-13-acetate (TPA) also activates C-kinase and is a potent stimulus for secretion and aggregation. It is shown here that the exogenous diacylglycerol 1-oleoyl-2-acetyl-glycerol (OAG) and TPA evoke similar secretion and aggregation without elevating [Ca2+]i above the basal level of 0.1 microM. The pattern of secretion resembles that produced by collagen and thrombin when [Ca2+]i remains at basal levels. Modest increases in [Ca2+]i, insufficient to stimulate secretion, markedly accelerate the responses to TPA and OAG.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6621685     DOI: 10.1038/305317a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  124 in total

1.  The effects of noradrenaline and adenosine 5'-triphosphate on polyphosphoinositide and phosphatidylcholine hydrolysis in arterial smooth muscle.

Authors:  J E Nally; T C Muir; S B Guild
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Exocytosis from permeabilized lactating mouse mammary epithelial cells. Stimulation by Ca2+ and phorbol ester, but inhibition of regulated exocytosis by guanosine 5'-[gamma-thio]triphosphate.

Authors:  M D Turner; C J Wilde; R D Burgoyne
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

3.  Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.

Authors:  B S Moonga; D W Moss; A Patchell; M Zaidi
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

4.  A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets.

Authors:  D L Nunn; S P Watson
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

5.  Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet.

Authors:  D de Chaffoy de Courcelles; P Roevens; H Van Belle
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

6.  Inhibition of ciliary activity by phorbol esters in rabbit tracheal epithelial cells.

Authors:  K Kobayashi; J Tamaoki; N Sakai; A Chiyotani; T Takizawa
Journal:  Lung       Date:  1989       Impact factor: 2.584

7.  Phospholipase D activation is functionally linked to superoxide generation in the human neutrophil.

Authors:  R W Bonser; N T Thompson; R W Randall; L G Garland
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

8.  The effects of 1-oleoyl-2-acetylglycerol on platelet protein phosphorylation and platelet ultrastructure.

Authors:  L L Friesen; J M Gerrard
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

9.  Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2.

Authors:  T J Hallam; A Sanchez; T J Rink
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

10.  The influence of cyclandelate on Ca++ translocation in human platelets.

Authors:  J W Akkerman; W E van den Hoven
Journal:  Drugs       Date:  1987       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.